Cardinal Health (CAH) Competitors $151.18 -0.39 (-0.26%) As of 10:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSICShould you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector. Cardinal Health vs. Its Competitors DexCom Hologic Merit Medical Systems AMN Healthcare Services Cencora Elevance Health Haemonetics Integer McKesson Henry Schein DexCom (NASDAQ:DXCM) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Does the media favor DXCM or CAH? In the previous week, Cardinal Health had 21 more articles in the media than DexCom. MarketBeat recorded 54 mentions for Cardinal Health and 33 mentions for DexCom. DexCom's average media sentiment score of 1.27 beat Cardinal Health's score of 0.89 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 24 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardinal Health 32 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is DXCM or CAH more profitable? DexCom has a net margin of 13.29% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.41% beat Cardinal Health's return on equity.Company Net Margins Return on Equity Return on Assets DexCom13.29% 30.41% 10.08% Cardinal Health 0.70%-74.45%4.14% Do analysts recommend DXCM or CAH? DexCom currently has a consensus target price of $99.90, suggesting a potential upside of 22.16%. Cardinal Health has a consensus target price of $163.20, suggesting a potential upside of 8.09%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Cardinal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 3 Strong Buy rating(s) 2.96Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has more risk & volatility, DXCM or CAH? DexCom has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Do institutionals and insiders hold more shares of DXCM or CAH? 97.8% of DexCom shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.1% of Cardinal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable earnings & valuation, DXCM or CAH? Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDexCom$4.03B7.95$576.20M$1.4456.79Cardinal Health$222.58B0.16$1.56B$6.4523.41 SummaryDexCom beats Cardinal Health on 13 of the 17 factors compared between the two stocks. Get Cardinal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAH vs. The Competition Export to ExcelMetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$36.43B$15.46B$5.81B$21.00BDividend Yield1.34%1.48%3.84%3.59%P/E Ratio23.6518.1030.5828.53Price / Sales0.162.42457.9052.88Price / Cash13.1116.3737.1523.84Price / Book-13.693.739.015.30Net Income$1.56B$472.13M$3.26B$992.10M7 Day Performance1.00%0.51%0.91%0.71%1 Month Performance-3.90%1.85%3.80%0.63%1 Year Performance36.73%12.41%30.02%11.04% Cardinal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAHCardinal Health4.8719 of 5 stars$150.99-0.4%$163.20+8.1%+38.4%$36.43B$222.58B23.6557,700Trending NewsDividend AnnouncementInsider TradeDXCMDexCom4.8211 of 5 stars$80.82-0.2%$99.89+23.6%+10.1%$31.69B$4.03B56.1310,300Positive NewsAnalyst ForecastHOLXHologic4.8597 of 5 stars$67.27-0.8%$78.00+16.0%-16.1%$14.96B$4.03B27.917,063Positive NewsAnalyst RevisionMMSIMerit Medical Systems4.4107 of 5 stars$86.16+0.8%$107.00+24.2%-5.8%$5.10B$1.36B43.747,400Positive NewsAMNAMN Healthcare Services4.4468 of 5 stars$19.43+2.7%$28.25+45.4%-61.5%$744.48M$2.98B-2.502,968CORCencora4.2354 of 5 stars$290.45-0.8%$311.25+7.2%+26.8%$56.31B$293.96B29.8846,000Positive NewsELVElevance Health4.8648 of 5 stars$310.03+0.1%$413.81+33.5%-42.9%$69.81B$177.01B13.19104,200News CoveragePositive NewsInsider TradeHAEHaemonetics4.9471 of 5 stars$53.25-0.9%$85.18+60.0%-28.3%$2.57B$1.36B16.283,023Positive NewsITGRInteger4.1426 of 5 stars$105.61-1.1%$140.25+32.8%-13.2%$3.70B$1.72B46.5211,000Positive NewsMCKMcKesson4.2439 of 5 stars$670.82-0.3%$719.27+7.2%+26.5%$83.44B$359.05B26.7545,000Positive NewsInsider TradeHSICHenry Schein4.1975 of 5 stars$67.22-0.9%$75.58+12.4%-2.4%$8.15B$12.67B21.6825,000Positive News Related Companies and Tools Related Companies DexCom Competitors Hologic Competitors Merit Medical Systems Competitors AMN Healthcare Services Competitors Cencora Competitors Elevance Health Competitors Haemonetics Competitors Integer Competitors McKesson Competitors Henry Schein Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CAH) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access